Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
45.1K
-
Shares change
-
-300K
-
Total reported value, excl. options
-
$216K
-
Value change
-
-$2.18M
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$4.80
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q4 2023
3 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q4 2023.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.1K shares
of 162M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include STATE STREET CORP (16.8M shares), VANGUARD GROUP INC (14.6M shares), BlackRock Inc. (8.44M shares), SHAH CAPITAL MANAGEMENT (7.78M shares), MORGAN STANLEY (7.24M shares), GEODE CAPITAL MANAGEMENT, LLC (2.3M shares), Rafferty Asset Management, LLC (1.61M shares), COATUE MANAGEMENT LLC (1.52M shares), BANK OF AMERICA CORP /DE/ (1.33M shares), and CITIGROUP INC (1.19M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.